List of programme's course units, number of exams (i.e. how many times the exam was taken in a year) and average marks
The data refer to last year. A course unit may include modules, subgroups, integrated exams. Proficiency tests are not included in the list.
Course unit | Number of times exam was taken | Average mark |
---|---|---|
ECONOMETRICS | 1 | 21 |
ACCOUNTING AND MANAGEMENT IN HEALTHCARE (I.C.) | 1 | 26 |
GLOBAL HEALTH POLICY | 8 | 27 |
MODELING IN ECONOMIC EVALUATION I | 2 | 26 |
FUNDAMENTALS OF ECONOMIC EVALUATION IN HEALTH CARE | 1 | 30 |
LEADERSHIP, MANAGEMENT AND ORGANIZATION DEVELOPMENT | 2 | 29 |
TOPICS IN GLOBAL HEALTH | 1 | 30 |
HEALTH ECONOMICS (I.C.) | 4 | 27 |
QUALITATIVE METHODS | 1 | 28 |
QUANTITATIVE METHODS IN HEALTH AND HEALTHCARE (I.C.) | 19 | 23 |
RESEARCH METHODS IN HEALTH AND HEALTH CARE (I.C.) | 7 | 26 |
FUNDAMENTAL IN HEALTH ECONOMICS AND MANAGEMENT (I.C.) | 60 | 26 |
INTERNATIONAL LAW AND HEALTH | 13 | 22 |
ETHICAL DECISION MAKING | 4 | 30 |
FUNDAMENTALS OF QUANTITATIVE METHODS IN HEALTH AND HEALTHCARE (I.C.) | 39 | 26 |
HEALTH ECONOMICS AND MANAGEMENT (I.C.) | 1 | 25 |
HEALTH ECONOMICS AND MANAGEMENT (I.C.) | 7 | 28 |
REGULATION AND COMPETITION IN HEALTH CARE MARKETS | 4 | 28 |
FUNDAMENTALS IN HEALTH ECONOMICS | 1 | 19 |
PUBLIC HEALTH MANAGEMENT (I.C.) | 4 | 27 |
HEALTH SYSTEMS | 51 | 26 |
HEALTH ECONOMETRICS | 3 | 26 |
HEALTH TECHNOLOGY ASSESSMENT (I.C.) | 11 | 26 |
RESEARCH METHODS IN HEALTH AND HEALTH CARE (I.C.) | 3 | 27 |
ECONOMICS OF THE BIOPHARMACEUTICAL INDUSTRY | 1 | 29 |
ADVANCED ECONOMIC EVALUATION | 1 | 27 |
NON-PARAMETRIC METHODS | 1 | 30 |
LINEAR REGRESSION ANALYSES | 4 | 30 |
HEALTH PROMOTION AND POLICIES (I.C.) | 1 | 27 |
INTERNATIONAL HEALTH LAW | 7 | 26 |
PHARMACEUTICAL MARKET AND HEALTHCARE ETHICS (I.C.) | 1 | 27 |
HEALTH ECONOMICS AND MANAGEMENT (I.C.) | 3 | 29 |
BEHAVIOURAL DECISION THEORY IN HEALTH | 1 | 27 |
HEALTH ECONOMICS AND POLICY IN LOW AND MIDDLE INCOME COUNTRIES | 2 | 27 |
OUR RIGHT TO HEALTH: NEEDS, RESOURCES AND SOCIETY | 56 | 25 |
MODELING IN ECONOMIC EVALUATION II | 2 | 28 |
FUNDAMENTALS OF MEDICINE I | 3 | 28 |
GLOBAL HEALTH ECONOMICS (I.C.) | 9 | 27 |
FINANCE AND INVESTMENT (I.C.) | 2 | 28 |
FUNDAMENTALS OF HEALTH LAW | 3 | 26 |
LEGAL ISSUES IN PHARMACEUTICAL MARKETS | 2 | 22 |
REAL LIFE SIMULATION: PRACTICE | 2 | 27 |
LIFESTYLES AND HEALTH OUTCOMES | 15 | 25 |
PHARMACEUTICAL PRICING AND MARKET ACCESS | 8 | 26 |
RESEARCH METHODS IN HEALTH AND HEALTH CARE (I.C.) | 3 | 28 |
NON-PARAMETRIC METHODS | 1 | 28 |
HEALTH SERVICES INNOVATION | 10 | 26 |
REAL LIFE SIMULATION: METHODS | 4 | 28 |
PLANNING AND EVALUATION OF HEALTH POLICY | 9 | 28 |
GLOBAL HEALTH ECONOMICS (GLOBAL HEALTH COURSE) | 1 | 22 |
METHODS FOR ESTIMATING THE EFFECTS OF INTERVENTIONS (I.C.) | 3 | 29 |
PRINCIPLES OF LEGAL THINKING IN EUROPEAN AND INTERNATIONAL LAW | 3 | 29 |
HEALTH ECONOMICS AND MANAGEMENT (I.C.) | 3 | 29 |
FUNDAMENTALS OF HEALTH CARE SYSTEMS | 3 | 29 |
LAW, REGULATION AND PLANNING IN HEALTHCARE (I.C.) | 4 | 26 |
COMPARATIVE HEALTH POLICY | 7 | 27 |